吸水链霉菌Streptomyces hygroscopicus 17997中噬菌体基因转移系统的建立及其应用

由吸水链霉菌Streptomyces hygroscopicus 17997产生的格尔德霉素geldanamycin(GA)属安莎类抗生素,具有良好的抗肿瘤和抗病毒活性。本文应用链霉菌温和噬菌体ΦC31衍生的KC515载体,在吸水链霉菌S．hygroscopicus 17997中建立并优化了S．hygroscopicus 17997的基因转染体系。利用所建立的基因转染体系,以基因阻断技术从S．hygroscopicus 17997基因文库含有多组PKS基因柯斯质粒中,鉴定了与GA PKS生物合成相关基因的柯斯质粒,该工作为GA生物合成基因簇的克隆奠定了基础。     

吸水链霉菌Streptomyces hygroscopicus 17997中噬菌体基因转移系统的建立及其应用

由吸水链霉菌Streptomyces hygroscopicus 17997产生的格尔德霉素geldanamycin(GA)属安莎类抗生素, 具有良好的抗肿瘤和抗病毒活性。本文应用链霉菌温和噬菌体C31衍生的KC515载体,在吸水链霉菌S.hygroscopicus 17997中建立并优化了S. hygroscopicus　17997的基因转染体系。利用所建立的基因转染体系,以基因阻断技术从S. hygroscopicus 17997基因文库含有多组PKS基因柯斯质粒中,鉴定了与GA PKS生物合成相关基因的柯斯质粒,该工作为GA生物合成基因簇的克隆奠定了基础。     

罗中链霉菌中衣霉素基因簇的克隆及异源表达

衣霉素属于核苷类抗生素,具有抑制蛋白质N-糖基化的活性,是潜在的药物先导化合物.罗中链霉菌(Streptomyces luozzhongensis)TRM49605是一株产衣霉素的链霉菌属(Streptomyces)的新物种.本研究旨在探索TRM49605中衣霉素生物合成基因簇的生物学功能,为新型药物开发提供理论依据.通过antiSMASH预测发现TRM49605中衣霉素基因簇全长29.394 kb,由26个基因组成,采用Red/ET方法通过线线重组成功构建了含有衣霉素PartⅡ片段的质粒pTRM605-24-01以及含有完整衣霉素生物合成基因簇的质粒pTRM605-24-02.通过线环重组将接合转移元件插入pTRM605-24-02获得pTRM605-24-03质粒,通过属间接合转移将衣霉素生物合成基因簇整合至天蓝色链霉菌(S. coelicolor)M145中进行表达.成功克隆获得衣霉素生物合成基因簇并异源表达,为改造衣霉素生物合成基因簇提供理论依据.     

海洋破囊壶菌Δ~4-脂肪酸脱饱和酶基因在酿酒酵母中的表达

以质粒pGEM-TFAD4为模板,扩增获得1.6kb的Δ4-脂肪酸脱饱和酶基因(FAD4)。将FAD4酶切后连接到HindⅢ/XbaⅠ处理过的pYES2.0载体,构建重组表达质粒pYFAD4。转化酿酒酵母缺陷型菌INVScl,通过SC-U选择性培养基筛选阳性克隆子。添加外源脂肪酸C22:5底物,半乳糖诱导表达。气相色谱分析表明阳性克隆子总脂肪酸中出现了二十二碳六烯酸C22:6(占酵母总脂肪含量的41.13%),Δ4-脂肪酸脱饱和酶基因在酿酒酵母中得到了表达。     

黑曲霉糖化酶高产菌株的糖化酶结构基因的分离及其序列分析

从糖化酶高产菌株(Aspergills niger)T21中分离出染色体DNA.Southern印跡分析表明糖化酶结构基因位于约2.5kb的EcoRⅠ-EcoRV片段中.该染色体DNA经EcorⅠ、EcoRⅤ完全酶切后,用琼脂糖凝胶电泳分离,回收2.0—3.0kb的片段,与载体pBR322连接后转化宿主菌大肠杆菌DH5,获得转化子.通过原位杂交,从转化子中筛选出4个阳性克隆.阳性克隆的进一步酶切鉴定及序列分析表明,黑曲霉T21糖化酶结构基因大小为2.3kb,含有4个内含子.     

沼气池宏基因组文库中未培养微生物β-葡萄糖苷酶基因的克隆与鉴定

以间接提取法提取了沼气池样品的微生物宏基因组DNA,用柯斯质粒载体pWEB:TNC构建了一个含三万个克隆的沼气池宏基因组文库,对文库中的克隆随机分析表明,该文库的外源片段平均长度为40 kb,文库的总容量为1 .2×106kb。对其中的一个在七叶苷平板上显色的阳性克隆pGXN100进行进一步亚克隆、测序和序列分析。结果表明,pGXN100上有一个全长为1 863bp的ORF,编码621个氨基酸组成的蛋白质。将该基因命名为Unglu100。与产气克雷伯菌属的一个β-葡萄糖苷酶基因AN292在核苷酸和氨基酸水平上分别有76%和85%的同源性,利用SMART软件进行预测表明,Unglu100可能是PTS中β-葡萄糖苷酶特异性的转运蛋白组件。     

格尔德霉素生物合成的调控基因

从吸水链霉菌17997中克隆了格尔德霉素(Geldanamycin, Gdm)生物合成酶基因簇, 通过生物信息学分析发现两个LAL(Large ATP-binding regulators of the LuxR family)家族的调控基因gdmRI和gdmRII, 基因阻断和基因回复实验证实这两个基因产物都正调控Gdm的生物合成。     

格尔德霉素生物合成的调控基因

从吸水链霉菌17997中克隆了格尔德霉素(Geldanamycin, Gdm)生物合成酶基因簇, 通过生物信息学分析发现两个LAL(Large ATP-binding regulators of the LuxR family)家族的调控基因gdmRI和gdmRII, 基因阻断和基因回复实验证实这两个基因产物都正调控Gdm的生物合成。     

宏基因组文库中的组成型启动子在大肠杆菌中的克隆

启动子是决定基因表达水平的重要因素之一。组成型表达启动子被认为是工业上表达重要蛋白质的理想启动子。本研究利用蔗糖为唯一碳源的基本培养基对榨糖废水浸润的土壤微生物宏基因组文库进行筛选,获得两个阳性克隆。对其中一个克隆的柯斯质粒进行亚克隆,利用在线启动子预测和序列比对工具对其中一个亚克隆子进行分析,获得一个启动子序列。然后,利用PCR方法将该启动子和地衣芽孢杆菌的α-淀粉酶基因一起克隆到T载体上。结果表明该启动子在不加诱导剂的条件下能够在大肠杆菌中启动外源基因的高效表达。本研究结果为在生物领域中组成型启动子的应用研究提供了基础。     

海洋破囊壶菌△4-脂肪酸脱饱和酶基因在酿酒母中的表达

以质粒pGEM-TFAD4为模板,扩增获得1.6 kb的△4-脂肪酸脱饱和酶基因(FAD4).将FAD4酶切后连接到Hond Ⅲ/XbaⅠ处理过的pYES2.0载体,构建重组表达质粒pYFAD4.转化酿酒酵母缺陷型菌INVScl,通过SC-U选择性培养基筛选阳性克隆子.添加外源脂肪酸C22:5底物,半乳糖诱导表达.气相色谱分析表明阳性克隆子总脂肪酸中出现了二十二碳六烯酸C22:6(占酵母总脂肪含量的41.13%),△4-脂肪酸脱饱和酶基因在酿酒酵母中得到了表达.     

Cloning and analysis of geldanamycin partial biosynthetic gene cluster of streptomyces hygroscopicus 17997

A geldanamycin (GDM)-producing strain, Streptomyces hygroscopicus 17997, was isolated from the soil of Yunnan, China, by the researchers of the Institute of Medicinal Biotechnology, CAMS & PUMC. GDM is an ansamycin antibiotic, which has the ability to bind with Hsp90 (heat shock protein 90) and alter its function. Hsp90 plays a key role in regulating the physiology of cells exposed to environmental stress and in maintaining the malignant phenotype of tumor cells. As an inhibitor of Hsp90, GDM possesses potent antitumoral and antiviral bioactivity, but the hypatotoxicity and poor solubility in water limit its clinical use. To accomplish the structural modification of GDM by genetic means, an attempt to obtain the biosynthetic gene cluster of GDM from S. hygroscopicus 17997 was made. In this study, a pair of primers was designed according to a conserved sequence of one of the possible post-PKS (polyketides synthase) modification genes, the carbamoyltransferase (CT) gene (gdmN) in GDM biosynthesis. The 732-bp PCR product was obtained from the S. hygroscopicus 17997 genomic DNA. Through the colony-PCR Binary Search Method, using the CT gene primers, six positive cosmid clones, CT1-6, were identified from the S. hygroscopicus 17997 cosmid genomic library. The CT-4 positive cosmid was then sub-cloned and sequenced. Approximately 28.356 kb of foreign gene sequence from CT-4 cosmid and by further PCR extension reaction was obtained. According to BLAST analysis, this sequence contains 13 possible ORFs, and they are believed to be involved in GDM production. The obtained possible GDM biosynthetic gene cluster in S. hygroscopicus 17997 will facilitate the further functional analysis of the genes and the modification of the structure of GDM through combinatorial biosynthesis.     

格尔德霉素生物合成基因功能的验证

格尔德霉素(Geldanamycin, Gdm)作为热休克蛋白90的特异性抑制剂, 是非常有前景的抗肿瘤和抗病毒的药物,我们已从吸水链霉菌17997(Streptomyces hygroscopicus 17997)的基因文库中获得了Gdm大部分生物合成基因。为了研究主要基因的功能, 选择了聚酮合酶基因(Polyketide synthase gene, pks)的第六模块、单加氧酶基因(Mono-oxygenase gene, gdmM)和氨甲酰基转移酶基因(Carbamoyltransferase gene, gdmN)3个基因作为靶点分别进行基因阻断, 获得了基因同源双交换的阻断变株△pks、△gdmM和△gdmN。经HPLC检测证实这些基因的阻断变株均不产生Gdm, 基因回复实验排除了基因阻断所可能造成的极性效应对其它基因表达的影响, 说明所克隆的pks、gdmM和gdmN基因确实是Gdm生物合成所必须的基因。     

Thiazinogeldanamycin, a new geldanamycin derivative produced by Streptomyces hygroscopicus 17997

A new geldanamycin (GDM) derivative was discovered and isolated from the fermentation broth of Streptomyces hygroscopicus 17997. Its chemical structure was elucidated as thiazinogeldanamycin by LC-MS, sulfur analysis, and NMR. The addition of cysteine to the fermentation medium significantly stimulated the production level of thiazinogeldanamycin, suggesting cysteine as a precursor of thiazinogeldanamycin production. Although showing a decreased cytotoxicity against HepG2 cancer cells, thiazinogeldanamycin exhibited an improved water solubility and photostability. Thiazinogeldanamycin may represent the first natural GDM derivative characterized so far that uses GDM as its precursor. Its appearance also clearly indicates that an appropriate end-point of fermentation is of critical importance for the maximal production of GDM by Streptomyces hygroscopicus 17997.     

Disruption of Heat Shock Protein 90 (Hsp90)-Protein Kinase Cδ (PKCδ) Interaction by (?)-Maackiain Suppresses Histamine H1 Receptor Gene Transcription in HeLa Cells

The histamine H₁ receptor (H1R) gene is an allergic disease sensitive gene, and its expression level is strongly correlated with the severity of allergic symptoms. (−)-Maackiain was identified as a Kujin-derived anti-allergic compound that suppresses the up-regulation of the H1R gene. However, the underlying mechanism of H1R gene suppression remains unknown. Here, we sought to identify a target protein of (−)-maackiain and investigate its mechanism of action. A fluorescence quenching assay and immunoblot analysis identified heat shock protein 90 (Hsp90) as a target protein of (−)-maackiain. A pull-down assay revealed that (−)-maackiain disrupted the interaction of Hsp90 with PKCδ, resulting in the suppression of phorbol 12-myristate 13-acetate (PMA)-induced up-regulation of H1R gene expression in HeLa cells. Additional Hsp90 inhibitors, including 17-(allylamino)-17-demethoxygeldanamycin, celastrol, and novobiocin also suppressed PMA-induced H1R gene up-regulation. 17-(Allylamino)-17-demethoxygeldanamycin inhibited PKCδ translocation to the Golgi and phosphorylation of Tyr³¹¹ on PKCδ. These data suggest that (−)-maackiain is a novel Hsp90 pathway inhibitor. The underlying mechanism of the suppression of PMA-induced up-regulation of H1R gene expression by (−)-maackiain and Hsp90 inhibitors is the inhibition of PKCδ activation through the disruption of Hsp90-PKCδ interaction. Involvement of Hsp90 in H1R gene up-regulation suggests that suppression of the Hsp90 pathway could be a novel therapeutic strategy for allergic rhinitis.     

快速鉴定格尔德霉素产生菌——吸水链霉菌17997中的洋橄榄叶素

对格尔德霉素产生菌吸水链霉菌17997的发酵液乙酸乙酯提取物进行了硅胶板TLC 初步分离和NaOH溶液喷涂显色,对显红色、具有抗革兰阳性菌活性的条带进行了HPLC分析,提示抗革兰阳性菌活性化合物可能为大环二内酯类抗生素洋橄榄叶素;以dTDP-葡萄糖-4,6-脱水酶 (Tgd) 基因保守区设计PCR引物,扩增了吸水链霉菌17997基因组DNA中的tgd并进行了序列分析,表明吸水链霉菌17997含有洋橄榄叶素生物合成基因簇中的tgd基因;对NaOH溶液喷涂显红色的化合物进行LC-(+)-ESI-MS分析,证实     

Synthesis and biological activities of novel 17-aminogeldanamycin derivatives

Geldanamycin interferes with the action of heat shock protein 90 (Hsp90) by binding to the N-terminal ATP binding site and inhibiting an essential ATPase activity. In a program directed toward finding potent, water soluble inhibitors of Hsp90, we prepared a library of over sixty 17-alkylamino-17-demethoxygeldanamycin analogs, and compared their affinity for Hsp90, ability to inhibit growth of SKBr3 mammalian cells, and in selected cases, water solubility. Over 20 analogs showed cell growth inhibition potencies similar to that of 17-allylamino-17-demethoxygeldanamycin (17-AAG), the front-runner geldanamycin analog that is currently in multiple clinical trials. Many of these analogs showed water solubility properties that were desirable for formulation. One of the most potent and water-soluble analogs in the series was 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin (17-DMAG), which was independently prepared by the NCI and will soon enter clinical trials. Importantly, the binding affinity of these analogs to the molecular target Hsp90 does not correlate well with their cytotoxicity in SKBr3 cells.     

高效液相色谱-串联质谱分析微量格尔德霉素类似物

安莎类抗生素例如利福霉素和安丝菌素,通常由一组化学结构相似的组分组成。格尔德霉素为苯安莎类抗生素,已经发现4个组分。本研究采用高效液相色谱-串联质谱方法对格尔德霉素(GDM)制品中的微量组分进行了分析,发现5个新的和1个已知的GDM类似物。依据质谱数据、结合GDM生物合成机制,对6个GDM类似物的化学结构进行了推测:分子式为C29H42N2O10的新化合物3个,分别为GDM安莎链上C2-C3、C4-C5和C8-C9之间的C-C双键变为单键并同时单羟基化的GDM衍生物;分子式为C28H38N2O8的新化合物2个,其中1个为17(或12,或4)-去甲氧基格尔德霉素,另1个为4,5-双氢-10,11-脱水-17-去甲基-17-羟基格尔德霉素;分子式为C29H42N2O9的已知化合物1个,为4,5-双氢格尔德霉素。这些GDM类似物的发现有助于加深对GDM生物合成的认识,并对通过基因阻断、组合生物合成技术获得GDM衍生物的研究有启示作用。     

17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration

Heat-shock protein 90 (Hsp90) functions as part of a multichaperone complex that folds, activates and assembles its client proteins. Androgen receptor (AR), a pathogenic gene product in spinal and bulbar muscular atrophy (SBMA), is one of the Hsp90 client proteins. We examined the therapeutic effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG), a potent Hsp90 inhibitor, and its ability to degrade polyglutamine-expanded mutant AR. Administration of 17-AAG markedly ameliorated motor impairments in the SBMA transgenic mouse model without detectable toxicity, by reducing amounts of monomeric and aggregated mutant AR. The mutant AR showed a higher affinity for Hsp90-p23 and preferentially formed an Hsp90 chaperone complex as compared to wild-type AR; mutant AR was preferentially degraded in the presence of 17-AAG in both cells and transgenic mice as compared to wild-type AR. 17-AAG also mildly induced Hsp70 and Hsp40. 17-AAG would thus provide a new therapeutic approach to SBMA and probably to other related neurodegenerative diseases.